The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Sentinel lymph node biopsy following neoadjuvant chemotherapy in clinically node-negative breast cancer patients.
K. Enokido
No relevant relationships to disclose
S. Nakamura
No relevant relationships to disclose
K. Tsugawa
No relevant relationships to disclose
Y. Kojima
No relevant relationships to disclose
H. Iwata
No relevant relationships to disclose
S. Ohno
No relevant relationships to disclose
F. Akiyama
No relevant relationships to disclose
K. Motomura
No relevant relationships to disclose